Two teams have shown that enhanced glucocorticoid signaling in the brain triggers aberrant behavior in mouse models of depression and anxiety. The groups are now studying the mechanisms underlying the effect to determine whether blocking glucocorticoid signaling could treat neuropsychiatric diseases.